SCHEMBL16845109

SCHEMBL16845109

Cc1noc(C)c1NC(=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 2/20 0.55
▸ P2RY14 Q15391 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.51
▸ TSHR P16473 2/20 0.51
▸ GAA P10253 2/20 0.49
▸ RIPK1 Q13546 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ LMNA P02545 2/20 0.47
▸ BRD2 P25440 1/20 0.47
▸ KDM1A O60341 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ TP53 P04637 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16845182 0.85 BRD4 (0.56) BRD4ALDH1A1GAARIPK1ATM
SCHEMBL1670485 0.84 BRD4 (0.66) BRD4ALDH1A1GAALMNABRD2
SCHEMBL14098961 0.82 RAB9A (0.61) BRD4P2RY14ALDH1A1GAARIPK1
SCHEMBL20511088 0.78 GAA (0.49) ALDH1A1TSHRGAALMNAPOLB
SCHEMBL3599701 0.77 BRD4 (0.46) BRD4ALDH1A1TSHRGAARIPK1
SCHEMBL16823776 0.76 HTT (0.46) BRD4ALDH1A1TSHRGAARIPK1
Hydrochloric Acid SCHEMBL1375757 0.76 BRD4 (0.45) BRD4ALDH1A1TSHRGAARIPK1
SCHEMBL8488339 0.75 BRD4 (0.55) BRD4ALDH1A1LMNABRD2KDM1A
SCHEMBL30359920 0.74 BRD4 (0.51) BRD4ALDH1A1KDM1AMAPTNPC1
SCHEMBL4774340 0.72 BRD4 (0.76) BRD4P2RY14ALDH1A1TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160318866-A1 SUBSTITUTED BIPIPERIDINYL DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-11-03 — — US disclosed
US-20160318866-A1 SUBSTITUTED BIPIPERIDINYL DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-11-03 — — US disclosed
WO-2015091415-A1 SUBSTITUTED BIPIPERIDINYL DERIVATIVES AS ADRENORECEPTOR ALPHA 2C ANTAGONISTS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318866-A1 SUBSTITUTED BIPIPERIDINYL DERIVATIVES TNNI3, TNNC1, FABP3 BRD4 1771/4885P2RY14 1198/4885ALDH1A1 3111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback